Abstract
Background
Adherence to clinical practice guidelines improves outcomes for patients with breast cancer. However, their implementation may not be feasible in low- and middle-income countries. This study aimed to evaluate physicians’ adherence, attitudes, and barriers towards the Colima Consensus, which is the Mexican national breast cancer clinical practice guideline.
Methods
A cross-sectional, 31-item survey was e-mailed to Consensus attendees and members of the Mexican Society of Oncology and Mexican Mastology Association. Descriptive statistics, univariate, and multivariate analysis were used to analyze the associations between participants’ characteristics, adherence, attitudes, and barriers.
Results
Of 439 respondents, 78% percent adhered to Consensus recommendations and 94% believed it was applicable to their clinical practice. Forty percent reported using the Consensus as their sole breast cancer guideline. This was associated with being a surgical oncologist (OR 3.3, 95% CI 2.0–5.3) and practicing at a public hospital (OR 2.1, 95% CI 1.2–3.7). The most common barriers to adherence were lack of resources and logistical problems. Regarding attitudes towards the Consensus, 90% considered it a good educational tool, 89% considered it a reliable source of information, and 90% thought it improved quality of care.
Conclusions
We showed high levels of adherence and positive attitudes towards the Colima Consensus, with a significant proportion of physicians using it as their only guideline. Lack of resources and logistical issues were the main barriers to adherence. Our results highlight the relevance of local breast cancer guidelines and suggest a need for the creation of resource-stratified guidelines.
Similar content being viewed by others
References
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021. https://doi.org/10.3322/caac.21660.
Chávarri-Guerra Y, Villarreal-Garza C, Liedke PER, et al. Breast cancer in Mexico: a growing challenge to health and the health system. Lancet Oncol. 2012;13:e335–43. https://doi.org/10.1016/S1470-2045(12)70246-2.
Institute of Medicine. Clinical practice guidelines: directions for a new program. Washington, DC: The national academies press; 1990.
Ricci-Cabello I, Vásquez-Mejía A, Canelo-Aybar C, et al. Adherence to breast cancer guidelines is associated with better survival outcomes: a systematic review and meta-analysis of observational studies in EU countries. BMC Health Serv Res. 2020;20:920. https://doi.org/10.1186/s12913-020-05753-x.
Bierbaum M, Rapport F, Arnolda G, et al. Clinicians’ attitudes and perceived barriers and facilitators to cancer treatment clinical practice guideline adherence: a systematic review of qualitative and quantitative literature. Implement Sci. 2020;15:39. https://doi.org/10.1186/s13012-020-00991-3.
Heins MJ, de Jong JD, Spronk I, et al. Adherence to cancer treatment guidelines: influence of general and cancer-specific guideline characteristics. Eur J Public Health. 2017;27:616–20. https://doi.org/10.1093/eurpub/ckw234.
Poncet B, Colin C, Bachelot T, et al. Treatment of metastatic breast cancer: a large observational study on adherence to French prescribing guidelines and financial cost of the anti-HER2 antibody trastuzumab. Am J Clin Oncol. 2009;32:369–74. https://doi.org/10.1097/COC.0b013e31818c08d3.
Wöckel A, Varga D, Atassi Z, et al. Impact of guideline conformity on breast cancer therapy: results of a 13-year retrospective cohort study. Onkologie. 2010;33:21–8. https://doi.org/10.1159/000264617.
Andreano A, Rebora P, Valsecchi MG, Russo AG. Adherence to guidelines and breast cancer patients survival: a population-based cohort study analyzed with a causal inference approach. Breast Cancer Res Treat. 2017;164:119–31. https://doi.org/10.1007/s10549-017-4210-z.
van de Water W, Bastiaannet E, Dekkers OM, et al. Adherence to treatment guidelines and survival in patients with early-stage breast cancer by age at diagnosis. Br J Surg. 2012;99:813–20. https://doi.org/10.1002/bjs.8743.
Yip CH, Buccimazza I, Hartman M, et al. Improving outcomes in breast cancer for low and middle income countries. World J Surg. 2015;39:686–92. https://doi.org/10.1007/s00268-014-2859-6.
Brand NR, Qu LG, Chao A, Ilbawi AM. Delays and barriers to cancer care in low- and middle-income countries: a systematic review. Oncologist. 2019;24:e1371–80. https://doi.org/10.1634/theoncologist.2019-0057.
National Comprehensive Cancer Network (2022) NCCN Framework for Resource Stratification of NCCN Guidelines (NCCN FrameworkTM). https://www.nccn.org/guidelines/nccn-framework-for-resource-stratification-of-nccn-guidelines. Accessed 10 Apr 2022
Yip CH, Anderson BO. The breast health global initiative: clinical practice guidelines for management of breast cancer in low- and middle-income countries. Expert Rev Anticancer Ther. 2007;7:1095–104. https://doi.org/10.1586/14737140.7.8.1095.
Consenso Mexicano sobre diagnóstico y tratamiento del cáncer mamario (2021) Consenso de Cáncer Mamario. http://consensocancermamario.com/. Accessed 12 Apr 2022
Cárdenas-Sánchez J. Mexican consensus on breast cancer diagnosis and treatment. Gac Mex Oncol. 2022. https://doi.org/10.24875/j.gamo.M21000215.
Balasubramanian SP, Murrow S, Holt S, et al. Audit of compliance to adjuvant chemotherapy and radiotherapy guidelines in breast cancer in a cancer network. Breast. 2003;12:136–41. https://doi.org/10.1016/s0960-9776(02)00263-1.
Sharma A, Minh Duc NT, Luu Lam Thang T, et al. A consensus-based checklist for reporting of survey studies (CROSS). J Gen Intern Med. 2021;36:3179–87. https://doi.org/10.1007/s11606-021-06737-1.
Jagsi R, Huang G, Griffith K, et al. Attitudes toward and use of cancer management guidelines in a national sample of medical oncologists and surgeons. J Natl Compr Cancer Netw. 2014;12:204–12. https://doi.org/10.6004/jnccn.2014.0021.
Graham ID, Evans WK, Logan D, et al. Canadian oncologists and clinical practice guidelines: a national survey of attitudes and reported use. provincial lung disease site group of cancer care ontario. Oncology. 2000;59:283–90. https://doi.org/10.1159/000012184.
Hinz EK, Kudesia R, Rolston R, et al. Physician knowledge of and adherence to the revised breast cancer screening guidelines by the United States preventive services task force. Am J Obstet Gynecol. 2011;205:201.e1-5. https://doi.org/10.1016/j.ajog.2011.04.025.
Foster JA, Abdolrasulnia M, Doroodchi H, et al. Practice patterns and guideline adherence of medical oncologists in managing patients with early breast cancer. J Natl Compr Cancer Netw. 2009;7:697–706. https://doi.org/10.6004/jnccn.2009.0049.
Institute of Medicine (US) Committee on Standards for Developing Trustworthy Clinical Practice Guidelines (2011) Clinical Practice Guidelines We Can Trust. National Academies Press (US), Washington, DC, US
Davis DA, Taylor-Vaisey A. Translating guidelines into practice. a systematic review of theoretic concepts, practical experience and research evidence in the adoption of clinical practice guidelines. CMAJ. 1997;157:408–16.
Gandhi S, Verma S, Ethier J-L, et al. A systematic review and quality appraisal of international guidelines for early breast cancer systemic therapy: are recommendations sensitive to different global resources? Breast. 2015;24:309–17. https://doi.org/10.1016/j.breast.2014.12.005.
EF Education First Ltd (2021) EF English Proficiency Index. A Ranking of 112 Countries and Regions by English Skills
Graham ID, Brouwers M, Davies C, Tetroe J. Ontario doctors’ attitudes toward and use of clinical practice guidelines in oncology. J Eval Clin Pract. 2007;13:607–15. https://doi.org/10.1111/j.1365-2753.2006.00670.x.
Ventura-Alfaro CE, Ávila-Burgos L, Torres-Mejía G. Adherence of Mexican physicians to clinical guidelines in the management of breast cancer: effect of the national catastrophic health expenditure fund. PLoS ONE. 2019;14:e0212841–e0212841. https://doi.org/10.1371/journal.pone.0212841.
Martinez-Cannon BA, Zertuche-Maldonado T, de la Rosa PS, et al. Comparison of characteristics in Mexican women with breast cancer according to healthcare coverage. Womens Health (Lond Engl). 2020;16:1745506520949416. https://doi.org/10.1177/1745506520949416.
Gomez Dantes O, Sesma S, Becerril VM, et al. The health system of Mexico. Salud Publica Mex. 2011;53(Suppl 2):s220–32.
Urquieta-Salomón JE, Villarreal HJ. Evolution of health coverage in Mexico: evidence of progress and challenges in the Mexican health system. Health Policy Plan. 2015;31:28–36. https://doi.org/10.1093/heapol/czv015.
Kerr S, Jazieh A-R, Kerr D. How useful are international treatment guidelines in low- and middle-income countries? J Glob Oncol. 2017;3:441–3. https://doi.org/10.1200/JGO.2016.008250.
Ralefala T, Mokokwe L, Jammalamadugu S, et al. Provider barriers and facilitators of breast cancer guideline-concordant therapy delivery in botswana: a consolidated framework for implementation research analysis. Oncologist. 2021;26:e2200–8. https://doi.org/10.1002/onco.13935.
Song CV, Yip C-H, Mohd Taib NA, et al. Association between adherence to clinical practice guidelines for adjuvant therapy for breast cancer and survival in a resource-limited setting. JCO Glob Oncol. 2022;8: e2100314. https://doi.org/10.1200/GO.21.00314.
Villarreal-Garza C, Mesa-Chavez F, Ferrigno AS, et al (2021) Adjuvant endocrine therapy for premenopausal women with breast cancer: Patient adherence and physician prescribing practices in Mexico. Breast 59:8–15. https://doi.org/10.1016/j.breast.2021.05.013
Acknowledgements
We wish to dedicate this manuscript in memory of Dr. Aura Erazo Valle-Solis, founder of the Colima Consensus, who passed away on May 23rd, 2022.
Funding
None.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Martinez-Cannon, B., Soto-Perez-de-Celis, E., Erazo Valle-Solis, A. et al. Physicians’ attitudes and perceived barriers to adherence to the national breast cancer clinical practice guidelines in Mexico: a survey study. Clin Transl Oncol 25, 151–159 (2023). https://doi.org/10.1007/s12094-022-02921-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12094-022-02921-9